Zdrowie i gospodarka · 23/04/2025

FDA Announces Second Year of Voluntary Quality Management Maturity Prototype Assessment Protocol Evaluation Program

The FDA is seeking a limited number of drug manufacturers to participate in the second year of a voluntary program to assess and refine quality management practices, with the goal of enabling consistent and meaningful assessments of participating establishments.